Description
Clenbuterol (4-amino-alpha-[(tert-butylamino)
methyl]-3,5-dichlorobenzyl alcohol hydrocholride), a beta-2-adrenergic
agonist, provides bronchodilating properties with minimum
effect on the cardiovascular system.
Features
Only FDA-approved solution for reversible
respiratory problems.
Treat-to-effect dose schedule provides optimum
level of treatment.
Duration of effect from 6 to 8 hours.
Colorless, palatable syrup provides for easy
oral administration.
Benefits
Relieves reversible bronchospasm arising from
a variety of respiratory conditions.
Increases mucous secretions for improved airway
resistance.
Improves mucociliary transport by decreasing
thickness of mucous.
Advantages
Only FDA-approved treatment to relieve reversible
bronchospasm from respiratory conditions such as allergy
induced respiratory distress, small airway disease or chronic
obstructive pulmonary disease (COPD).
|
Dosage
& Administration
Remove safety cap and seal; replace with enclosed
dispensing cap. Connect syringe (without needle) to dispensing
tip and draw out appropriate volume of VENTIPULMIN
Syrup (clenbuterol hydrochloride). Administer to horse orally
twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body
weight (0.8 mcg/kg)twice daily. See package insert for complete
dasage schedule. Recommended duration of treatment at effective
dose is 30 days. At end of 30-day treatment perild, drug
should be withdrawn to determine recurrence of signs. If
signs return, repeat 30-day treatment regimen.
Precautions
Store at controlled room temperature (15-30
degrees C) 59-86 degrees F. Avoid freezing. The safety cap
should be placed on the bottle when not in use. VENTIPULMIN
Syrup should not be used in pregnant mares near term or
in horses suspected of having cardiovascular impairment.
|
Uses
VENTIPULMIN Syrup (clenbuterol hydrochloride)
is indicated for management of horses affected with airway
obstruction, such as chronic obstructive pulmonary disease
(COPD),
Warning
This product is not for human use or for use
in animals intended for food. Federal (U.S.AA.) law restricts
this drug to use by or on the order of a licensed veterinarian.
The reproduction effect in breeding stallions and brood
mares has not been determined. Treatment starting with dosages
higher than initial dose is not recommended. Keep out of
reach of children. In case of accidental ingestion, contact
a physician immediately. Clenbuterol, like other beta adrenergic
agonists, can produce significant cardiovascular effects
in some people as evidenced by elevated pulse rate, blood
pressure changes and/or ECG changes.
Product
Information
| Name |
Code |
Size |
| VENTIPULMIN |
301-715 |
100 mL |
| Syrup |
301-725 |
330 mL |
|